title: Metastatic cutaneous squamous cell carcinoma responding to erlotinib therapy.
authors.forename: Candace
authors.initials: C
authors.lastname: Engelhardt
authors.forename: Clara
authors.initials: C
authors.lastname: Curiel-Lewandrowski
authors.forename: James
authors.initials: J
authors.lastname: Warneke
authors.forename: Lee
authors.initials: L
authors.lastname: Cranmer
mesh_terms: D001365:Axilla; D001707:Biopsy, Needle; D002294:Carcinoma, Squamous Cell / Q000556:secondary* / Q000601:surgery; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D000069347:Erlotinib Hydrochloride; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000473:pathology*; D009367:Neoplasm Staging; D011799:Quinazolines / Q000627:therapeutic use*; D012782:Shoulder; D012878:Skin Neoplasms / Q000473:pathology* / Q000601:surgery; D016896:Treatment Outcome
chemical_list: D011799:Quinazolines; D000069347:Erlotinib Hydrochloride